CSRXP: SENATE FINANCE REPORT HIGHLIGHTS BIG PHARMA’S EGREGIOUS PRACTICES THAT RAISE INSULIN PRICES
Jan 14, 2021
Bipartisan Investigation Details How Drug Companies Work in Tandem to Hike… Read More
© 2025 CSRXP- All Rights Reserved
Updates
BIG PHARMA WATCH: NEW STUDY FINDS DRUG COMPANIES CONTINUING TO HIKE PRICES WITHOUT IMPROVING THEIR DRUGS
Jan 13, 2021
Unjustified Rx Price Increases Cost American Patients & Health System… Read More
CSRxP STATEMENT ON PCMA LAWSUIT CHALLENGING TRUMP ADMINISTRATION’S REBATE RULE
Jan 12, 2021
Misguided Policy Published in Violation of Legally Required Process for Public… Read More
BIG PHARMA WATCH: HEADLINES FROM BIG PHARMA’S NEW YEAR PRICE HIKES
Jan 11, 2021
Second Major Round of Pandemic Price Increases Underscores Urgency for… Read More
HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 580 RX DRUGS TO START 2021
Jan 4, 2021
Drug Companies Double Down In Second Major Round Of Pandemic Price Hikes As… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 31, 2020
Part IV: Escalating Assault on 340B Program for Providers Serving America’s… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 30, 2020
Part III: Angling to Price-Gouge American Public on COVID-19 Treatments… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 29, 2020
Part II: Gaming the System to Undermine Competition at the Expense of American… Read More
“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR
Dec 28, 2020
Part I: Sticking with Price-Hiking “Business-as-Usual” During Pandemic… Read More
TWO BIRDS OF A FEATHER: ASTRAZENECA TO ACQUIRE FELLOW PRICE-GOUGER ALEXION IN MULTI-BILLION DOLLAR DEAL
Dec 14, 2020
In case you missed it, Big Pharma giant AstraZeneca announced plans to acquire… Read More
CSRXP STATEMENT ON SELECTION OF XAVIER BECERRA FOR THE U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES
Dec 7, 2020
Campaign Looks Forward to Working with Becerra to Lower Drug Prices… Read More
CSRXP: BIG PHARMA MUST BE HELD ACCOUNTABLE FOR ESCALATING ASSAULT ON CRITICAL 340B PROGRAM
Dec 3, 2020
Novo Nordisk Becomes Latest Drug Company to Dodge Requirement to Provide… Read More